Novartis Pharmaceuticals v. Accord Healthcare Inc.
SUN PHARMACEUTICAL INDUSTRIES LTD., HETERO USA INC., APOTEX INC., TORRENT PHARMACEUTICALS LTD., ZYDUS PHARMACEUTICALS (USA) INC., ACCORD HEALTHCARE INC., TORRENT PHARMA INC., DR. REDDYS LABORATORIES, INC., GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS, HETERO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES INC., STRIDES GLOBAL PHARMA PRIVATE LIMITED, APOTEX CORP., CADILA HEALTHCARE LIMITED, AUROBINDO PHARMA LIMITED, MYLAN PHARMACEUTICALS, INC., STRIDES PHARMA, INC., PRINSTON PHARMACEUTICAL INC., HERITAGE PHARMACEUTICALS INC., AUROBINDO PHARMA USA, INC., DR. REDDYS LABORATORIES, LTD., HETERO LABS LIMITED UNIT-V and SUN PHARMA GLOBAL FZE |
NOVARTIS PHARMACEUTICALS CORPORATION |
HEC PHARM USA INC. and HEC PHARM CO., LTD. |
21-1070 |
October 20, 2020 |
U.S. Court of Appeals, Federal Circuit |
Other |
Opinions
We have the following opinions for this case:
Description |
---|
Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. |
NOVARTIS PHARMACEUTICALS v. ACCORD HEALTHCARE INC. |
Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. |
Docket Report
This docket was last retrieved on November 3, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 7 Docketing Statement for the Appellee Novartis Pharmaceuticals Corporation. Service: 11/03/2020 by email. [733285] [21-1070] [Jane Love] [Entered: 11/03/2020 12:06 PM] |
Filing 6 Certificate of Interest for Appellee Novartis Pharmaceuticals Corporation. Service: 11/03/2020 by email. [733283] [21-1070] [Jane Love] [Entered: 11/03/2020 12:01 PM] |
Filing 5 Entry of appearance for Jane M. Love, Ph.D.; Robert Trenchard; Paul E. Torchia as counsel for Appellee Novartis Pharmaceuticals Corporation. Service: 11/03/2020 by email. [733282] [21-1070] [Jane Love] [Entered: 11/03/2020 11:59 AM] |
Filing 4 Certificate of Interest for Appellants HEC Pharm Co., Ltd. and HEC Pharm USA Inc.. Service: 11/03/2020 by email. [733245] [21-1070] [Paul Skiermont] [Entered: 11/03/2020 11:06 AM] |
Filing 3 Docketing Statement for the Appellants HEC Pharm Co., Ltd. and HEC Pharm USA Inc.. Service: 11/03/2020 by email. [733244] [21-1070] [Paul Skiermont] [Entered: 11/03/2020 11:03 AM] |
Filing 2 Entry of appearance for Paul J. Skiermont; Mieke K. Malmberg; Sarah E. Spires as counsel for Appellants HEC Pharm Co., Ltd. and HEC Pharm USA Inc.. Service: 11/03/2020 by email. [733241] [21-1070] [Paul Skiermont] [Entered: 11/03/2020 11:00 AM] |
Filing 1 Appeal docketed. Received: 10/09/2020. [730131] Entry of Appearance is due on 11/03/2020. Certificate of Interest is due on 11/03/2020. Docketing Statement is due on 11/03/2020. Appellant's brief is due on 12/21/2020. [KMH] [Entered: 10/20/2020 10:50 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.